Cytokinetics Scores A First-Ever In Its Rivalry Against Bristol Myers

Cytokinetics scored the first-ever win for a Phase 3 study in non-obstructive hypertrophic cardiomyopathy on Friday. The post Cytokinetics Scores A First-Ever In Its Rivalry Against Bristol Myers appeared first on Investor's Business Daily.